<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nogr</journal-id><journal-title-group><journal-title xml:lang="ru">Экспериментальная и клиническая гастроэнтерология</journal-title><trans-title-group xml:lang="en"><trans-title>Experimental and Clinical Gastroenterology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-8658</issn><publisher><publisher-name>«Global Media Technologies»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.31146/1682-8658-ecg-187-3-146-151</article-id><article-id custom-type="elpub" pub-id-type="custom">nogr-1610</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ ГАСТРОЭНТЕРОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL GASTROENTEROLOGY</subject></subj-group></article-categories><title-group><article-title>Значимость генотипирования в диагностике ассоциированного с С- вирусным гепатитом артрита</article-title><trans-title-group xml:lang="en"><trans-title>Significance of genotyping in the diagnosis of arthritis associated with C-viral hepatitis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шукурова</surname><given-names>Ф. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Shukurova</surname><given-names>F. N.</given-names></name></name-alternatives><email xlink:type="simple">fazilatshukurova@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Парпибоева</surname><given-names>Д. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Parpiboeva</surname><given-names>D. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каримов</surname><given-names>М. Ш.</given-names></name><name name-style="western" xml:lang="en"><surname>Karimov</surname><given-names>M. Sh.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ташкентская медицинская академия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Tashkent medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>22</day><month>05</month><year>2021</year></pub-date><volume>0</volume><issue>3</issue><fpage>146</fpage><lpage>151</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шукурова Ф.Н., Парпибоева Д.А., Каримов М.Ш., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Шукурова Ф.Н., Парпибоева Д.А., Каримов М.Ш.</copyright-holder><copyright-holder xml:lang="en">Shukurova F.N., Parpiboeva D.A., Karimov M.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.nogr.org/jour/article/view/1610">https://www.nogr.org/jour/article/view/1610</self-uri><abstract><p>На сегодняшний день были проведены ряд исследований о взаимосвязи генотипов ВГС с такими осложнениями, как цирроз печени, гепатоцеллюлярная карцинома, исследовательских работы о корреляции генотипа с внепеченочными клиническими проявлениями, связанными с ВГС, особенно ревматическими проявлениями, недостаточно. Цель исследования - провести анализ наиболее распространенных генотипов вирусного гепатита С в Республике Узбекистан и изучить их корреляцию с ревматическими проявлениями ХВГС. Методы: В этом исследовании приняли участие 88 пациентов, инфицированных ВГС, получавших стационарное и в последующем амбулаторное лечение в НИИЭМИЗ Республика Узбекистан. Диагностика процедуры на исходном уровне включали комплекс исследований, т. е. клинический, ревматологический, клинико-лабораторные исследования, УЗИ сустава. А также, было проведено генотипирование 88 образцов РНК - положительной сыворотки пациентов с диагнозом ХГВС. Нуклеотидные последовательности продуктов амплификации определяли методом прямого секвенирования. Результаты: Результаты показали, что генотип 1 ВГС (подтип 1b) является основным генетическим вариантом ВГС в Узбекистане. На основании данных полученных результатов, что генотипические особенности вирусов могут являться маркерами развития внепеченочных клинических проявлений. Имеется достоверная прямая взаимосвязь встречаемости и выраженности ассоциированного артрита у больных хроническим вирусным гепатитом С с генотипом 1b вируса по данным наших исследований. Выводы: Результаты исследования можно предоставить в помощь врачу поликлинической службы в качестве рекомендаций, что у больных с 1b генотип вируса приверженность к ассоциированному артриту, больше и в этом случае необходима своевременная целенаправленная консультация специалиста.</p></abstract><trans-abstract xml:lang="en"><p>To date, a number of studies have been conducted on the relationship of HCV genotypes with complications such as liver cirrhosis, hepatocellular carcinoma, but research on the correlation of the genotype with extrahepatic clinical manifestations associated with HCV, especially rheumatic manifestations, is insufficient. The purpose of the study is to analyze the most common genotypes of viral hepatitis C in the Republic of Uzbekistan and study their correlation with rheumatic manifestations of HCV. Methods: This study involved 88 patients with HCV infection who received inpatient and subsequent ambulatornoe treatment in Scientific Research Institute of Epidemiology, Microbiology and Infectious diseases of the Republic of Uzbekistan. Diagnostics procedures at the initial level included a set of studies, i. e. clinical, rheumatological and laboratory studies, ultrasound of the joint. In addition, 88 samples of RNA - positive serum from patients diagnosed with HCV were genotyped. Results: the Results showed that genotype 1 of HCV (subtype 1b) is the main genetic variant of HCV in Uzbekistan. Based on the results obtained, the genotypic features of viruses can be markers of the development of extrahepatic clinical manifestations. There is a reliable direct correlation between the incidence and severity of associated arthritis in patients with chronic viral hepatitis C with genotype 1b of the virus according to our research. Conclusions: The results of the study can be provided to help the doctor of the polyclinic service as recommendations that patients with the 1b genotype of the virus have a greater adherence to associated arthritis, and in this case, timely targeted consultation of a specialist is necessary.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>вирусный гепатит С</kwd><kwd>генотип</kwd><kwd>генотипирование</kwd><kwd>секвенирование</kwd></kwd-group><kwd-group xml:lang="en"><kwd>viral hepatitis C</kwd><kwd>genotype</kwd><kwd>genotyping</kwd><kwd>sequencing</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Islambekova Z. A. Measures aiming to decrease hepatitis B and C morbidity rates may help prevent hepatocellular carcinoma in Uzbekistan, Onkologiya. 2009, no. 2, pp. 154-157. (In Russ.)@@ Исламбекова З. А. Снижение заболеваемости в Узбекистане вирусными гепатитами В и С - составляющая профилактики гепатоцеллюлярной карциномы. Онкология. -2009-11 № 2 - С. 154-157.</mixed-citation><mixed-citation xml:lang="en">Islambekova Z. A. Measures aiming to decrease hepatitis B and C morbidity rates may help prevent hepatocellular carcinoma in Uzbekistan, Onkologiya. 2009, no. 2, pp. 154-157. (In Russ.)@@ Исламбекова З. А. Снижение заболеваемости в Узбекистане вирусными гепатитами В и С - составляющая профилактики гепатоцеллюлярной карциномы. Онкология. -2009-11 № 2 - С. 154-157.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ananjeva L.P., Ignatova N. V., Smirnov A. V. Chronic erosive seropositive arthritis in a patient with chronic hepatitis C. Rheumatology Science and Practice. 2008;46(1):78-84. (In Russ.) Doi: 10.14412/1995-4484-2008-857</mixed-citation><mixed-citation xml:lang="en">Ananjeva L.P., Ignatova N. V., Smirnov A. V. Chronic erosive seropositive arthritis in a patient with chronic hepatitis C. Rheumatology Science and Practice. 2008;46(1):78-84. (In Russ.) Doi: 10.14412/1995-4484-2008-857</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Alvarado-Mora M.V, Pinho J. R. Epidemiological update of hepatitis B, C and delta in Latin America. Antivir Ther. 2013, no.18, pp. 429-433.</mixed-citation><mixed-citation xml:lang="en">Alvarado-Mora M.V, Pinho J. R. Epidemiological update of hepatitis B, C and delta in Latin America. Antivir Ther. 2013, no.18, pp. 429-433.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Rosner I., Rozenbaum M., Toubi E., Kessel A., Naschitz J. E., and Zuckerman E. The case for hepatitis C arthritis. Semin Arthritis Rheum. 2004, no. 33, pp. 375-387.</mixed-citation><mixed-citation xml:lang="en">Rosner I., Rozenbaum M., Toubi E., Kessel A., Naschitz J. E., and Zuckerman E. The case for hepatitis C arthritis. Semin Arthritis Rheum. 2004, no. 33, pp. 375-387.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Muhin N. A., Lopatkina T. N., Ignatova T. M., et al. Vnepechenochnie proyavleniya khronicheskih zabolevaniy pecheni, Klinicheskaya gepatologiya. 2008, no. 4, pp. 34-39. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Muhin N. A., Lopatkina T. N., Ignatova T. M., et al. Vnepechenochnie proyavleniya khronicheskih zabolevaniy pecheni, Klinicheskaya gepatologiya. 2008, no. 4, pp. 34-39. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Baranov A.B., Maleev V. V. Immunologicheskie pokazateli pri hronicheskom techenii gepatita С. nfectious diseases. 2008, vol. 6, no. 1, pp. 13-15. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Baranov A.B., Maleev V. V. Immunologicheskie pokazateli pri hronicheskom techenii gepatita С. nfectious diseases. 2008, vol. 6, no. 1, pp. 13-15. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Nakano T., Lau G. M., Sugiyama M., Mizokami M. An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver Int. 2012, no. 32, pp. 339-345.</mixed-citation><mixed-citation xml:lang="en">Nakano T., Lau G. M., Sugiyama M., Mizokami M. An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver Int. 2012, no. 32, pp. 339-345.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Poordad F, Dieterich D. Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents. J Viral Hepat. 2012, no. 19 (7): pp. 449-464.</mixed-citation><mixed-citation xml:lang="en">Poordad F, Dieterich D. Treating hepatitis C: current standard of care and emerging direct-acting antiviral agents. J Viral Hepat. 2012, no. 19 (7): pp. 449-464.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Tanaka Y., Kurbanov F., Mano S., et al. Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology. 2006, no. 130, pp. 703-714.</mixed-citation><mixed-citation xml:lang="en">Tanaka Y., Kurbanov F., Mano S., et al. Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality. Gastroenterology. 2006, no. 130, pp. 703-714.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kurbanov F., Tanaka Y., Sugauchi F., et al. Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol. 2003, no. 69, pp. 367-375.</mixed-citation><mixed-citation xml:lang="en">Kurbanov F., Tanaka Y., Sugauchi F., et al. Hepatitis C virus molecular epidemiology in Uzbekistan. J Med Virol. 2003, no. 69, pp. 367-375.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Bazarniy V., et al. Analiz chastoti serologicheskih markyorov virusnih gepatitov u donorov. Kliniko-laboratorniy konsilium. 2010, no. 1, pp. 58-60.</mixed-citation><mixed-citation xml:lang="en">Bazarniy V., et al. Analiz chastoti serologicheskih markyorov virusnih gepatitov u donorov. Kliniko-laboratorniy konsilium. 2010, no. 1, pp. 58-60.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Bel’tyukov P. P. Immunologicheskie metodi. Medicinskaya immunologiya. 2005, vol.7, no. 2-3, pp. 272-286.</mixed-citation><mixed-citation xml:lang="en">Bel’tyukov P. P. Immunologicheskie metodi. Medicinskaya immunologiya. 2005, vol.7, no. 2-3, pp. 272-286.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
